Quick Search

 

 


 

 

Result Summary for 107484

Result Summary
Protocol ID: 107484
Clinical Study ID: APV107484
Official Title: A Phase I, Randomized, Open Label, Four Arm, Two Period, Two 2X2, Crossover, Drug Interaction Study to Assess Steady-State Plasma Amprenavir and Phenytoin Pharmacokinetics following Administraction of Fosamprenavir 700mg BID + Ritonavir 100mg BID + Phenytoin 300mg QD, Fosamprenavir 700mg BID + R ...
Phase: Phase 1
Study Indications or Diseases:
  • Infection, Human Immunodeficiency Virus
Generic Name: fosamprenavir
Trade/Product Name: Telzer,Telzir,Lexiva
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.